Current Approaches in Hepatoblastoma-New Biological Insights to Inform Therapy.
Wu PV, Rangaswami A.
Curr Oncol Rep. 2022 Sep;24(9):1209-1218. doi: 10.1007/s11912-022-01230-2. Epub 2022 Apr 19.
Hepatoblastoma and Pediatric Hepatocellular Carcinoma: An Update.
Ranganathan S, Lopez-Terrada D, Alaggio R.
Pediatr Dev Pathol. 2020 Mar-Apr;23(2):79-95. doi: 10.1177/1093526619875228. Epub 2019 Sep 25.
Hepatoblastoma.
Sharma D, Subbarao G, Saxena R.
Semin Diagn Pathol. 2017 Mar;34(2):192-200. doi: 10.1053/j.semdp.2016.12.015. Epub 2016 Dec 23.
Single-cell analysis of hepatoblastoma identifies tumor signatures that predict chemotherapy susceptibility using patient-specific tumor spheroids.
Song H, Bucher S, Rosenberg K, Tsui M, Burhan D, Hoffman D, Cho SJ, Rangaswami A, Breese M, Leung S, Ventura MVP, Sweet-Cordero EA, Huang FW, Nijagal A, Wang B.
Nat Commun. 2022 Aug 25;13(1):4878. doi: 10.1038/s41467-022-32473-z.
Surgical management in hepatoblastoma: points to take.
Murawski M, Weeda VB, Czauderna P.
Pediatr Surg Int. 2023 Jan 12;39(1):81. doi: 10.1007/s00383-022-05356-z.
DNA methylation in Hepatoblastoma-a literature review.
Shen G, Shen H, Zhang J, Yan Q, Liu H.
Ital J Pediatr. 2020 Aug 5;46(1):113. doi: 10.1186/s13052-020-00877-6.
Surgical Pathology Diagnostic Pitfalls of Hepatoblastoma.
Morgan Auld F, Sergi CM.
Int J Surg Pathol. 2022 Aug;30(5):480-491. doi: 10.1177/10668969211070178. Epub 2022 Jan 20.
Identification and experimental validation of druggable epigenetic targets in hepatoblastoma.
Clavería-Cabello A, Herranz JM, Latasa MU, Arechederra M, Uriarte I, Pineda-Lucena A, Prosper F, Berraondo P, Alonso C, Sangro B, García Marin JJ, Martinez-Chantar ML, Ciordia S, Corrales FJ, Francalanci P, Alaggio R, Zucman-Rossi J, Indersie E, Cairo S, Domingo-Sàbat M, Zanatto L, Sancho-Bru P, Armengol C, Berasain C, Fernandez-Barrena MG, Avila MA.
J Hepatol. 2023 Oct;79(4):989-1005. doi: 10.1016/j.jhep.2023.05.031. Epub 2023 Jun 10.
Hepatoblastoma in an 11-year-old: Case report and a review of the literature.
Pateva IB, Egler RA, Stearns DS.
Medicine (Baltimore). 2017 Jan;96(2):e5858. doi: 10.1097/MD.0000000000005858.
A TGF-beta-dominant chemoresistant phenotype of hepatoblastoma associated with aflatoxin exposure in children.
Xiang X, Hao Y, Cheng C, Hu H, Chen H, Tan J, Wang Y, Liu X, Peng B, Liao J, Wang J, Xie Y, Liu J, Chen S, Xu L, Xie W, Xue R, Kuang M, Xu Z, Jiang H, Peng S.
Hepatology. 2024 Mar 1;79(3):650-665. doi: 10.1097/HEP.0000000000000534. Epub 2023 Jul 17.
